New studies show a recently approved drug for Hepatitis C doubles the cure rate of the standard treatment. We discuss the new treatment, and the disease that affects nearly four million Americans and is linked to about 12,000 deaths a year.
Guests:
Natalie Bzowej, director of clinical viral hepatitis at the California Pacific Medical Center and principal investigator on the clinical trials that led to the approval of the new Hepatitis C medication
Orlando Chavez, Hepatitis coordinator at the Berkeley Free Clinic
Sponsored